Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProHance vs Gadovist in Brain MRI (TRUTH)
NCT01613417Phase 4Completed
- Sponsor
- Bracco Diagnostics Inc.
- Start
- Aug 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gadoteridol in brain tumor, sponsored by Bracco Diagnostics Inc.. Started Aug 2012; status: completed.
02
Drugs
gadoteridol
03
Conditions
brain tumor
Beyond the preview
Go deeper on NCT01613417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01613417.